Peer-led prep support for young people in Brazil
Part of Infections clinical trials.
This study tests whether a peer-led program helps young people in Brazil start and stay on PrEP, a daily pill that prevents HIV. You would either get support from a trained peer or the usual care, and the goal is to see which works better for preventing HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 15 to 24 years old
- You are sexually active
- You have not tested positive for HIV
- You are not currently taking PrEP
- You are willing to discuss taking oral PrEP
- You agree to be randomly assigned to either the peer-led program or standard care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study tests a program to help men who have sex with men start and stick with PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to use and reduce HIV risk.
This study tests a counseling program to help more people who could benefit from PrEP (a pill that prevents HIV) actually start taking it. If you're a healthcare provider or someone looking for HIV prevention, this study might help improve access to PrEP.
This study tests a support program to help young women stick with their HIV prevention medicine (PrEP). It aims to see if extra support helps them keep taking it regularly.
This study compares different ways to help young men learn about and choose PrEP, a medicine that prevents HIV. It aims to see which approach works best for starting and staying on PrEP.
This study helps people at higher risk of HIV get access to PrEP, a daily medication that prevents HIV infection. The program focuses on underserved communities in Rio de Janeiro and aims to make PrEP easier to access and use.
Hear when a new Pre-Exposure Prophylaxis (PrEP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.